Top Markets
#1 MON MON +2,757.44%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +46.60%
#4 eCash eCash +31.94%
#5 Siren Siren +23.75%
#6 SAFEcoin SAFEcoin +19.98%
#7 Janction Janction +18.96%
#8 PinGo PinGo +15.95%
#9 Velvet Velvet +15.57%
#10 Beldex Beldex +13.32%
Coin of the day
MON MON
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Clasificación en acciones #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Precio por acción
$0.30780727
Capitalización bursátil
$94.19M
Cambio (1 día)
-0.19%
Cambio (1 año)
-34.73%
País
FR
Comercio Sensorion SA (ALSEN)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Sensorion SA (ALSEN)
La acción Sensorion SA (símbolo: ALSEN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jul 13, 2026.
Una acción ALSEN comprada antes de Jul 13, 2026 equivaldría hoy a 0 acciones ALSEN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5 x199
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL